WallStreetZenWallStreetZen

NASDAQ: CORT
Corcept Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Corcept Therapeutics revenue was $675.04M for the trailing 12 months ending Dec 31, 2024, with 32.4% growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $181.9M, down 0.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CORT annual revenue was $675.0M, with 39.9% growth year-over-year.

CORT past revenue growth

How has CORT's revenue growth performed historically?

Company
39.94%
Industry
421.43%
Market
20.21%
CORT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CORT's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CORT's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CORT revenue history

Current Revenue
$675.0M
Current Earnings
$139.7M
Current Profit Margin
20.7%

Be the first to know when CORT announces revenue.

CORT Revenue History By Year

CORT Yearly RevenueCORT RevenueCORT ChangeCORT Revenue Growth
2024-12-31$675.04M$192.67M+39.94%
2023-12-31$482.38M$80.52M+20.04%
2022-12-31$401.86M$35.88M+9.80%
2021-12-31$365.98M$12.10M+3.42%
2020-12-31$353.87M$47.39M+15.46%
2019-12-31$306.49M$55.24M+21.99%
2018-12-31$251.25M$92.05M+57.82%
2017-12-31$159.20M$77.88M+95.77%
2016-12-31$81.32M$31.04M+61.72%
2015-12-31$50.29M$23.74M+89.39%
2014-12-31$26.55M$16.19M+156.36%
2013-12-31$10.36M$7.05M+213.18%
2012-12-31$3.31MN/AN/A
2011-12-31$0.00N/AN/A
2010-12-31$0.00-$29.00k-100.00%
2009-12-31$29.00k-$180.00k-86.12%
2008-12-31$209.00k-$273.00k-56.64%
2007-12-31$482.00k$188.00k+63.95%
2006-12-31$294.00kN/AN/A
2005-12-31$0.00N/AN/A
2004-12-31$0.00N/AN/A
2003-12-31$0.00N/AN/A
2002-12-31$0.00N/AN/A
2001-12-31$0.00N/AN/A

1 of 2

Corcept Therapeutics Revenue FAQ

What was CORT's revenue last quarter?

On Invalid Date, Corcept Therapeutics (NASDAQ: CORT) reported Q4 2024 revenue of $181.89 million up 34.33% year over year. In the same quarter last year, Corcept Therapeutics's revenue was $135.41 million.

What was Corcept Therapeutics's revenue in 2024?

Corcept Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $675.04 million, a 39.94% increase year over year.

How much does Corcept Therapeutics make in a day?

Based on Corcept Therapeutics annual revenue for the past five years, CORT makes an average of $1,248,835.62 per day.

What was Corcept Therapeutics's annual revenue growth in the past year?

As of Q1 2025, Corcept Therapeutics's revenue has grown 39.94% year over year. This is 381.49 percentage points lower than the US Biotechnology industry revenue growth rate of 421.43%. Corcept Therapeutics's revenue in the past year totaled $675.04 million.

How much does Corcept Therapeutics make in a year?

Corcept Therapeutics's revenue by year for the past five years is:
  • Corcept Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $675.04 million, a 39.94% increase year over year.
  • Corcept Therapeutics's annual revenue for Dec 31, 2023 was $482.38 million, a 20.04% increase from 2022.
  • Corcept Therapeutics's annual revenue for 2022 was $401.86 million, a 9.8% increase from 2021.
  • Corcept Therapeutics's annual revenue for 2021 was $365.98 million, a 3.42% increase from 2020.
  • Corcept Therapeutics's annual revenue for 2020 was $353.87 million, a 15.46% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.